For the first time, the Russian influenza vaccine, whose final stages of production are carried out at the MECHNIKOV Latin American Biotechnology Institute in Nicaragua, is used by the Ministry of Health of this country as part of the vaccination of people.
The flu prevention campaign is taking place in Nicaragua from August 5 to September 28 – this is the second and most ambitious phase of the Ministry of Health’s action plan. Given Nicaragua’s geographical location in the Southern Hemisphere, the first phase of influenza vaccination there takes place in spring.
In total, 770 thousand doses of Russian-Nicaraguan influenza vaccine will be used in Nicaragua this year. The transfer of technology of the final stages of the drug development was carried out by the St. Petersburg Scientific Research Institute of Vaccines and Serums of the Federal Medical and Biological Agency of Russia within the framework of the implemented project, MECHNIKOV Institute.
As a reminder, on April 10, 2019, the MECHNIKOV Institute launched production (bottling and packaging) of commercial batches of the vaccine in Managua. The project has been implemented pursuant to the Instruction of Vladimir Putin, the President of the Russian Federation.
MECHNIKOV Institute has become a new stage of collaboration of Russia with Latin American countries and a new brand with Russian participation in the Central America opening the window of opportunities to improve the health care level in the whole region. The project has been implemented in close cooperation and with support of the Pan American Health Organization (PAHO). As Viktor Trukhin, Director of the Saint-Petersburg scientific research institute of vaccines and serums (SPbSRIVS), noted at the startup of the enterprise, the facilities of MECHNIKOV Institute allow producing up to 30 million doses of influenza vaccine per season.